Article Information
History
- January 30, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Frederick Berro Rivera, MD1,
- Grace Nooriza O. Lumbang, MD2,
- Danielle Rose Magno Gaid, MD2,
- Linnaeus Louisse A. Cruz, MD3,
- John Vincent Magalong, MD3,
- Nathan Ross B. Bantayan, BSc3,
- Kyla M. Lara-Breitinger, MD4,
- Martha Gulati, MD MS4 and
- George Bakris, MD6,*
- 1Department of Medicine, Lincoln Medical Center, New York, NY, USA
- 2Cebu Institute of Medicine, Cebu City, Philippines
- 3University of the Philippines College of Medicine, Manila, Philippines
- 4Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, (MN), USA
- 5Department of Cardiology, Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA
- 6Department of Medicine, University of Chicago, Chicago (IL), USA
- ↵*Address for Correspondence: George Bakris, MD, University of Chicago, Goldblatt Pavilion, 5841 S Maryland Ave, Chicago, IL 606337, Email: gbakris{at}gmail.com
Posted January 30, 2024.
Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
